HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intestinal Neoplasms (Intestinal Cancer)

Tumors or cancer of the INTESTINES.
Also Known As:
Intestinal Cancer; Cancer of the Intestines; Intestines Cancer; Intestines Neoplasms; Neoplasms, Intestinal; Cancer, Intestinal; Cancer, Intestines; Cancers, Intestinal; Cancers, Intestines; Intestinal Cancers; Intestinal Neoplasm; Intestines Cancers; Intestines Neoplasm; Neoplasm, Intestinal; Neoplasm, Intestines; Neoplasms, Intestines; Cancer of Intestines
Networked: 523 relevant articles (21 outcomes, 57 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Carcinogenesis
2. Neoplasm Metastasis (Metastasis)
3. Neoplasms (Cancer)
4. Breast Neoplasms (Breast Cancer)
5. Colonic Neoplasms (Colon Cancer)

Experts

1. Thompson, Chad M: 5 articles (01/2021 - 05/2014)
2. Harris, Mark A: 4 articles (10/2019 - 05/2014)
3. Stover, Patrick J: 4 articles (05/2018 - 12/2009)
4. Hanušová, Veronika: 4 articles (11/2017 - 10/2013)
5. Králová, Věra: 4 articles (11/2017 - 10/2013)
6. Skálová, Lenka: 4 articles (11/2017 - 10/2013)
7. Grady, William M: 4 articles (01/2017 - 10/2006)
8. Kim, Juil: 3 articles (05/2020 - 09/2014)
9. Moon, Yuseok: 3 articles (05/2020 - 09/2014)
10. Di Leo, Alfredo: 3 articles (04/2020 - 04/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Intestinal Neoplasms:
1. BombesinIBA
08/15/1994 - "Although the combined use of DAP with bombesin had little or no influence on the location, size, histological features, or depth of involvement of intestinal cancers, the incidence of their metastasis was significantly reduced. "
01/01/2001 - "Although verapamil administered at either dose had little or no effect on the enhancement of intestinal carcinogenesis by bombesin or on the location, histologic type, depth of involvement, labeling index, apoptotic index or tumor vascularity of intestinal cancers, it significantly decreased the incidence of cancer metastasis. "
05/01/2000 - "Although genistein administered at either dose had little or no effect on the enhancement of intestinal carcinogenesis by bombesin or on the location, histologic type, depth of involvement, labeling index, or growth pattern of intestinal cancers, it significantly decreased the incidence of cancer metastasis. "
11/01/1997 - "Although administration of a higher dose of ginsenoside Rg3 with bombesin had little or no effect on the enhancement of intestinal carcinogenesis by bombesin, the location, histologic type, depth of involvement, infiltrating growth pattern, labeling and apoptotic indices and tumor vascularity of intestinal cancers, it significantly decreased the incidence of cancer metastasis. "
07/01/1996 - "Although administration of both doses of triamterene with bombesin had little or no influence on the enhancement of intestinal carcinogenesis by bombesin, or the location, histologic type, depth of invasion, or labeling index of intestinal cancers, it significantly reduced the incidence of cancer metastasis. "
2. Dimenhydrinate (DMH)FDA LinkGeneric
3. AzoxymethaneIBA
4. Dietary FiberFDA Link
5. SeleniumIBA
6. EnzymesIBA
7. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
8. Paclitaxel (Taxol)FDA LinkGeneric
9. SesquiterpenesIBA
10. Prostaglandins EIBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Radiotherapy
4. Cholecystectomy
5. Transplantation